SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company: Xenon Pharmaceuticals Inc.
Filed: February 16, 2016
Accession Number: 0000921895-16-003420

View Document ↗ View on SEC.gov ↗